Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Chile

Chile Articles

Industry

BMI View: The legislation on bioequivalent drugs is an important step in bringing high quality medicines to the Chilean market and eventually reducing the country's medical expenditure.... 2013-01-03


Industry

BMI View: Corporación Farmacéutica Recalcine (CFR)'s foreign expansion strategy is likely to bring significant commercial returns. Mergers and acquisitions (M&A) facilitate market... 2012-03-27


Industry

BMI View: Multinational healthcare companies are seeking expansion in Chile through acquisitions of local distributors to avoid high production costs, which are due to the strict regulation... 2012-01-31


More ARTICLES

Industry

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10


Industry

BMI View: While we believe Chile's pharmaceutical industry is short-sighted and self-serving in its opposition to new government bioequivalence certification standards, we concede that... 2011-11-04


Industry

BMI View: Bucking a global push towards over-the-counter (OTC) medicines, governments across Latin America have responded to a series of scandals by clamping down on pharmacy sales.... 2011-10-28


Industry

BMI View: Although testament to the region's increasing growth potential, we believe foreign investments into pharmacy chains and local pharmaceutical companies have far-reaching implications... 2011-10-19


Industry

BMI View: Despite copper exports driving Chile's solid economic growth, the country's continuing struggle with social inequality has left many citizens struggling to meet their healthcare... 2011-10-03